Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Teva Pharmaceuticals USA, Inc recalls Octreotide Acetate for Injectable Suspension

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
Products
  • Octreotide Acetate for Injectable Suspension
Where it was sold

Nationwide in the USA

Nationwide

Units affected
19,869 Cartons
About this recall
Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg, Single-dose 8 mL vial in Kit, Rx only, Manufactured in Greece BY: Pharmathen International S.A, Rodopi, 693 00 Greece, Manufactured For: TEVA Pharmaceuticals, Parsippany, NJ 07054, NDC 0480-9259-08.